Efficacy of Myofunctional Therapy in Class II Patients

August 10, 2022 updated by: Sulma Milena Suarez, Fundación Universitaria CIEO

Efficacy of Myofunctional Therapy in Class II Patients With Functional Orthopedic Appliances. ECA

Randomized clinical trial , with a sample of 60 children with atypical swallowing, class II and with SN1 orthopedic appliances these patients were randomly divided into, group 1: 30 patients with SN1 orthopedic appliances and myofunctional therapy and group 2: 30 patients with SN1 orthopedic appliances and without myofunctional therapy.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Randomized clinical trial with two parallel arms, on a sample of 60 children with atypical swallowing, class II and with SN1 orthopedic appliances, these patients were randomly divided into, group 1: 30 patients with SN1 orthopedic appliances and myofunctional therapy and group 2: 30 patients with SN1 orthopedic appliances and without myofunctional therapy for the study. Both groups carried out the evaluation of the protocol that included: 1) evaluation of the dental occlusion class and skeletal classification 2) swallowing function test using the Payne technique; 3) Mioscaner analysis to measure perioral forces, i.e. tongue extension force, lip pressure, masseter contraction force.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 12 years (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • the inclusion criteria the participants will be between

    • 8 and 10 years old
    • mixed dentition
    • canine class II diagnosis and 2 to 4 mm
    • molar according to Angle and overjet between 4 to 6 mm

Exclusion Criteria:

  • Patients with systemic involvement

    • congenital malformations
    • facial deformities
    • Open bite
    • oral breathing
    • finger sucking habit will be excluded

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Group 1, with myofunctional therapy and SN1 functional orthopedic appliances
The participant will receive a session of myofunctional therapy every month, for 9 months. In this group, a series of procedures and techniques are carried out to create and mechanize muscular and orofacial patterns at rest and in function, eliminate habits, correct muscular imbalance, improve the aesthetics of the patient and normalize the functions of the stomatognathic system.
Group 1, with myofunctional therapy and SN1 functional orthopedic appliances The participant underwent a myofunctional therapy session every month, for 9 months. In this group, a series of procedures and techniques are carried out to create and mechanize muscular and orofacial patterns at rest and in function, eliminate habits, correct muscular imbalance, improve the aesthetics of the patient and normalize the functions of the stomatognathic system. The myofunctional therapy performed will be by an expert speech therapist
Other Names:
  • Orthopedics
EXPERIMENTAL: Group 2, without myofunctional therapy and SN1 functional orthopedic appliances.
Once the investigation is finished, the patient will decide whether or not to perform myofunctional therapy one every month, for 9 months.
Group 1, with myofunctional therapy and SN1 functional orthopedic appliances The participant underwent a myofunctional therapy session every month, for 9 months. In this group, a series of procedures and techniques are carried out to create and mechanize muscular and orofacial patterns at rest and in function, eliminate habits, correct muscular imbalance, improve the aesthetics of the patient and normalize the functions of the stomatognathic system. The myofunctional therapy performed will be by an expert speech therapist
Other Names:
  • Orthopedics

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Therapy Efficacy / Tongue Position
Time Frame: 9 months
Lingual projection force
9 months
41 / 5000 Resultados de traducción Efficacy of therapy / mandibular advancement
Time Frame: 9 months
It induces changes in the position of the mandibular bone towards a more advanced position
9 months
Muscle contraction
Time Frame: 9 months
Physiological process in which the muscles develop tension and are shortened or stretched by a stimulus
9 months
Contraction of the masseter muscles and muscle activity of the chin
Time Frame: 9 months
101 / 5000 Resultados de traducción Physiological process in which the muscles develop tension and are shortened or stretched by a stimulus
9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

December 22, 2022

Primary Completion (ANTICIPATED)

December 22, 2022

Study Completion (ANTICIPATED)

December 31, 2022

Study Registration Dates

First Submitted

March 1, 2021

First Submitted That Met QC Criteria

July 14, 2021

First Posted (ACTUAL)

July 23, 2021

Study Record Updates

Last Update Posted (ACTUAL)

August 11, 2022

Last Update Submitted That Met QC Criteria

August 10, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 111

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Efficacy

Clinical Trials on Myofuncional Therapy

3
Subscribe